Report Detail

Other Global Huntington’s Disease Treatment Market Size, Status and Forecast 2019-2025

  • RnM2683518
  • |
  • 12 July, 2019
  • |
  • Global
  • |
  • 96 pages
  • |
  • QYResearch
  • |
  • Other

Global Huntington’s Disease Treatment Market Size, Status and Forecast 2019-2025

Table of Contents

    1 Report Overview

    • 1.1 Study Scope
    • 1.2 Key Market Segments
    • 1.3 Players Covered
    • 1.4 Market Analysis by Type
      • 1.4.1 Global Huntington’s Disease Treatment Market Size Growth Rate by Type (2014-2025)
      • 1.4.2 Symptomatic Therapy
      • 1.4.3 Disease-Modifying Therapy
    • 1.5 Market by Application
      • 1.5.1 Global Huntington’s Disease Treatment Market Share by Application (2014-2025)
      • 1.5.2 Hospitals
      • 1.5.3 Ambulatory Surgical Centers
    • 1.6 Study Objectives
    • 1.7 Years Considered

    2 Global Growth Trends

    • 2.1 Huntington’s Disease Treatment Market Size
    • 2.2 Huntington’s Disease Treatment Growth Trends by Regions
      • 2.2.1 Huntington’s Disease Treatment Market Size by Regions (2014-2025)
      • 2.2.2 Huntington’s Disease Treatment Market Share by Regions (2014-2019)
    • 2.3 Industry Trends
      • 2.3.1 Market Top Trends
      • 2.3.2 Market Drivers
      • 2.3.3 Market Opportunities

    3 Market Share by Key Players

    • 3.1 Huntington’s Disease Treatment Market Size by Manufacturers
      • 3.1.1 Global Huntington’s Disease Treatment Revenue by Manufacturers (2014-2019)
      • 3.1.2 Global Huntington’s Disease Treatment Revenue Market Share by Manufacturers (2014-2019)
      • 3.1.3 Global Huntington’s Disease Treatment Market Concentration Ratio (CR5 and HHI)
    • 3.2 Huntington’s Disease Treatment Key Players Head office and Area Served
    • 3.3 Key Players Huntington’s Disease Treatment Product/Solution/Service
    • 3.4 Date of Enter into Huntington’s Disease Treatment Market
    • 3.5 Mergers & Acquisitions, Expansion Plans

    4 Breakdown Data by Type and Application

    • 4.1 Global Huntington’s Disease Treatment Market Size by Type (2014-2019)
    • 4.2 Global Huntington’s Disease Treatment Market Size by Application (2014-2019)

    5 United States

    • 5.1 United States Huntington’s Disease Treatment Market Size (2014-2019)
    • 5.2 Huntington’s Disease Treatment Key Players in United States
    • 5.3 United States Huntington’s Disease Treatment Market Size by Type
    • 5.4 United States Huntington’s Disease Treatment Market Size by Application

    6 Europe

    • 6.1 Europe Huntington’s Disease Treatment Market Size (2014-2019)
    • 6.2 Huntington’s Disease Treatment Key Players in Europe
    • 6.3 Europe Huntington’s Disease Treatment Market Size by Type
    • 6.4 Europe Huntington’s Disease Treatment Market Size by Application

    7 China

    • 7.1 China Huntington’s Disease Treatment Market Size (2014-2019)
    • 7.2 Huntington’s Disease Treatment Key Players in China
    • 7.3 China Huntington’s Disease Treatment Market Size by Type
    • 7.4 China Huntington’s Disease Treatment Market Size by Application

    8 Japan

    • 8.1 Japan Huntington’s Disease Treatment Market Size (2014-2019)
    • 8.2 Huntington’s Disease Treatment Key Players in Japan
    • 8.3 Japan Huntington’s Disease Treatment Market Size by Type
    • 8.4 Japan Huntington’s Disease Treatment Market Size by Application

    9 Southeast Asia

    • 9.1 Southeast Asia Huntington’s Disease Treatment Market Size (2014-2019)
    • 9.2 Huntington’s Disease Treatment Key Players in Southeast Asia
    • 9.3 Southeast Asia Huntington’s Disease Treatment Market Size by Type
    • 9.4 Southeast Asia Huntington’s Disease Treatment Market Size by Application

    10 India

    • 10.1 India Huntington’s Disease Treatment Market Size (2014-2019)
    • 10.2 Huntington’s Disease Treatment Key Players in India
    • 10.3 India Huntington’s Disease Treatment Market Size by Type
    • 10.4 India Huntington’s Disease Treatment Market Size by Application

    11 Central & South America

    • 11.1 Central & South America Huntington’s Disease Treatment Market Size (2014-2019)
    • 11.2 Huntington’s Disease Treatment Key Players in Central & South America
    • 11.3 Central & South America Huntington’s Disease Treatment Market Size by Type
    • 11.4 Central & South America Huntington’s Disease Treatment Market Size by Application

    12 International Players Profiles

    • 12.1 Valeant Pharmaceuticals
      • 12.1.1 Valeant Pharmaceuticals Company Details
      • 12.1.2 Company Description and Business Overview
      • 12.1.3 Huntington’s Disease Treatment Introduction
      • 12.1.4 Valeant Pharmaceuticals Revenue in Huntington’s Disease Treatment Business (2014-2019)
      • 12.1.5 Valeant Pharmaceuticals Recent Development
    • 12.2 Teva Pharmaceuticals
      • 12.2.1 Teva Pharmaceuticals Company Details
      • 12.2.2 Company Description and Business Overview
      • 12.2.3 Huntington’s Disease Treatment Introduction
      • 12.2.4 Teva Pharmaceuticals Revenue in Huntington’s Disease Treatment Business (2014-2019)
      • 12.2.5 Teva Pharmaceuticals Recent Development
    • 12.3 Wave Life Sciences
      • 12.3.1 Wave Life Sciences Company Details
      • 12.3.2 Company Description and Business Overview
      • 12.3.3 Huntington’s Disease Treatment Introduction
      • 12.3.4 Wave Life Sciences Revenue in Huntington’s Disease Treatment Business (2014-2019)
      • 12.3.5 Wave Life Sciences Recent Development
    • 12.4 Ionis Pharmaceuticals/ Roche
      • 12.4.1 Ionis Pharmaceuticals/ Roche Company Details
      • 12.4.2 Company Description and Business Overview
      • 12.4.3 Huntington’s Disease Treatment Introduction
      • 12.4.4 Ionis Pharmaceuticals/ Roche Revenue in Huntington’s Disease Treatment Business (2014-2019)
      • 12.4.5 Ionis Pharmaceuticals/ Roche Recent Development
    • 12.5 Raptor Pharmaceuticals
      • 12.5.1 Raptor Pharmaceuticals Company Details
      • 12.5.2 Company Description and Business Overview
      • 12.5.3 Huntington’s Disease Treatment Introduction
      • 12.5.4 Raptor Pharmaceuticals Revenue in Huntington’s Disease Treatment Business (2014-2019)
      • 12.5.5 Raptor Pharmaceuticals Recent Development
    • 12.6 Prana Biotechnology
      • 12.6.1 Prana Biotechnology Company Details
      • 12.6.2 Company Description and Business Overview
      • 12.6.3 Huntington’s Disease Treatment Introduction
      • 12.6.4 Prana Biotechnology Revenue in Huntington’s Disease Treatment Business (2014-2019)
      • 12.6.5 Prana Biotechnology Recent Development

    13 Market Forecast 2019-2025

    • 13.1 Market Size Forecast by Regions
    • 13.2 United States
    • 13.3 Europe
    • 13.4 China
    • 13.5 Japan
    • 13.6 Southeast Asia
    • 13.7 India
    • 13.8 Central & South America
    • 13.9 Market Size Forecast by Product (2019-2025)
    • 13.10 Market Size Forecast by Application (2019-2025)

    14 Analyst's Viewpoints/Conclusions

      15 Appendix

      • 15.1 Research Methodology
        • 15.1.1 Methodology/Research Approach
          • 15.1.1.1 Research Programs/Design
          • 15.1.1.2 Market Size Estimation
          • 12.1.1.3 Market Breakdown and Data Triangulation
        • 15.1.2 Data Source
          • 15.1.2.1 Secondary Sources
          • 15.1.2.2 Primary Sources
      • 15.2 Disclaimer

      Medications for movement disorders. Drugs to treat movement disorders include the following: Tetrabenazine (Xenazine) is specifically approved by the Food and Drug Administration to suppress the involuntary jerking and writhing movements (chorea) associated with Huntington's disease.
      Increased uptake of improved symptomatic therapies, promising disease-modifying therapies in the developmental pipeline, rise in target population, and favorable government initiatives are some of the key factors contributing to market growth.
      In 2018, the global Huntington’s Disease Treatment market size was xx million US$ and it is expected to reach xx million US$ by the end of 2025, with a CAGR of xx% during 2019-2025.

      This report focuses on the global Huntington’s Disease Treatment status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Huntington’s Disease Treatment development in United States, Europe and China.

      The key players covered in this study
      Valeant Pharmaceuticals
      Teva Pharmaceuticals
      Wave Life Sciences
      Ionis Pharmaceuticals/ Roche
      Raptor Pharmaceuticals
      Prana Biotechnology
      ...

      Market segment by Type, the product can be split into
      Symptomatic Therapy
      Disease-Modifying Therapy

      Market segment by Application, split into
      Hospitals
      Ambulatory Surgical Centers

      Market segment by Regions/Countries, this report covers
      United States
      Europe
      China
      Japan
      Southeast Asia
      India
      Central & South America

      The study objectives of this report are:
      To analyze global Huntington’s Disease Treatment status, future forecast, growth opportunity, key market and key players.
      To present the Huntington’s Disease Treatment development in United States, Europe and China.
      To strategically profile the key players and comprehensively analyze their development plan and strategies.
      To define, describe and forecast the market by product type, market and key regions.

      In this study, the years considered to estimate the market size of Huntington’s Disease Treatment are as follows:
      History Year: 2014-2018
      Base Year: 2018
      Estimated Year: 2019
      Forecast Year 2019 to 2025
      For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.


      Summary:
      Get latest Market Research Reports on Huntington’s Disease Treatment . Industry analysis & Market Report on Huntington’s Disease Treatment is a syndicated market report, published as Global Huntington’s Disease Treatment Market Size, Status and Forecast 2019-2025. It is complete Research Study and Industry Analysis of Huntington’s Disease Treatment market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.


      REPORT YOU MIGHT BE INTERESTED

      Purchase this Report

      $3,900.00
      $5,850.00
      $7,800.00
      3,117.69
      4,676.54
      6,235.38
      3,472.34
      5,208.51
      6,944.68
      420,030.00
      630,045.00
      840,060.00
      268,557.90
      402,836.85
      537,115.80
      Credit card Logo

      Related Reports


      Reason to Buy

      Request for Sample of this report